[ET Net News Agency, 12 November 2026] HANSOH PHARMA (03692) rose 3.1% to HK$35.44.
It hits an intra-day high of HK$35.44, breaking above the 250-D SMA of HK$34.842, and an intra-day low of HK$33.78. The total shares traded was 3.68 million, with a value of HK$127.27m. The active buy/sell ratio is 76:24, with net buying turnover of HK$62.63m. MERRILL LYNCH FE accounts for greatest net responsive buying turnover of HK$4.89m, with volume weighted average price of HK$34.528. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$12.19m, with volume weighted average price of HK$34.516.
The Hang Seng Index now fell 207 points, or 0.9% to 24,108; the Hang Seng China Enterprises Index now fell 77 points, or 1% to 8,093.
Basic Information| Nominal | 35.440 | % Chg | +3.14% |
| High | 35.440 | Low | 33.780 |
| Shares Tr | 3.68m | Turnover | 127.27m |
| 10-D SMA | 34.006 | %H.V | 54.948 |
| 20-D SMA | 33.338 | VWAP | 34.540 |
| 50-D SMA | 33.676 | RSI14 | 59.493 |
Status: Breaking above the 250-D SMA, active buy/sell ratio is 76:24, with net buying turnover of HK$62.63m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 35.440 | +3.14 |
| SIHUAN PHARM (00460) | 0.805 | Unchanged |
| GRAND PHARMA (00512) | 4.365 | -0.11 |
| SBP GROUP (01177) | 5.620 | +1.54 |
| HENGRUI PHARMA (01276) | 50.600 | +0.70 |
| LIVZON PHARMA (01513) | 24.720 | +0.41 |
| LUYE PHARMA (02186) | 1.670 | -0.89 |
| FOSUN PHARMA (02196) | 16.680 | -0.30 |
| SH PHARMA (02607) | 11.020 | -0.09 |
| CHINARES PHARMA (03320) | 4.495 | -0.99 |
(ed)
Nominal 
